Company History

  • December 2008

    China Biologic acquired 90% controlling interest in Guiyang Dalin Biologic Technologies Co., Ltd., which owned 54% equity interests in Guiyang Qianfeng Biological Products Co., Ltd. (“Qianfeng”), one of the largest plasma-based biopharmaceutical companies in China with 250 metric tons s in annual plasma collection volume and one plasma manufacturing facility with a 400 metric ton capacity. Qianfeng changed its name to Guizhou Taibang Biological Products Co.,Ltd. later.
  • August 2008

    Shandong Taibang completed the construction of an additional fractionation facility, renewed its GMP Certification, and more than doubled its annual production capacity to 700 metric tons of plasma.
  • January 2007

    Shandong Taibang acquired assets of two plasma stations in Guangxi Province.
  • December 2006

    Shandong Taibang acquired assets of five plasma stations in Shandong Province.
FirstPage | PreviousPage | NextPage | LastPage CurrentPageIndex:9 [2] [3] [4] [5] [6] [7] [8] [9] [10] 
© 2017 China Biologic Products Holdings, Inc. All Rights Reserved.